SCHEMBL20906310

SCHEMBL20906310

CCC(N)C(=O)Nc1ccc(Oc2ccc(C)c(OC)c2)nc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 5/20 0.48
LTA4H P09960 1/20 0.43
KMT2A Q03164 5/20 0.42
ALDH1A1 P00352 4/20 0.42
POLB P06746 1/20 0.42
MEN1 O00255 4/20 0.41
PABPC1 P11940 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
KDM4E B2RXH2 2/20 0.41
RECQL P46063 1/20 0.41
LMNA P02545 1/20 0.41
MAPT P10636 3/20 0.40
RAB9A P51151 1/20 0.40
CASP3 P42574 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
GAA P10253 1/20 0.40
MAPK1 P28482 1/20 0.40
TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1978742 1.00 AAK1 (0.48) AAK1LTA4HKMT2AALDH1A1POLB
SCHEMBL1983127 1.00 AAK1 (0.48) AAK1LTA4HKMT2AALDH1A1POLB
Hydrochloric Acid SCHEMBL21980915 0.99 AAK1 (0.47) AAK1LTA4HKMT2AALDH1A1POLB
Hydrochloric Acid SCHEMBL13720612 0.99 AAK1 (0.47) AAK1LTA4HKMT2AALDH1A1POLB
SCHEMBL12593841 0.90 AAK1 (0.48) AAK1LTA4HKMT2AALDH1A1POLB
SCHEMBL1980493 0.89 XIAP (0.46) AAK1LTA4HKMT2AALDH1A1POLB
SCHEMBL20568098 0.88 RAB9A (0.42) AAK1LTA4HALDH1A1KDM4EMAPT
SCHEMBL13721199 0.88 RAB9A (0.42) AAK1LTA4HALDH1A1KDM4EMAPT
SCHEMBL12594175 0.88 KMT2A (0.47) AAK1LTA4HKMT2AALDH1A1POLB
SCHEMBL12594162 0.87 MAPT (0.43) LTA4HKMT2AALDH1A1POLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200163964-A1 IMIDAZOLIDINEDIONE DERIVATIVES AUTIFONY THERAPEUTICS LIMITED (GB) 2020-05-28 US disclosed
US-10265316-B2 Hydantoin derivatives useful as Kv3 inhibitors AUTIFONY THERAPEUCTICS LIMITED (GB) 2019-04-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200163964-A1 IMIDAZOLIDINEDIONE DERIVATIVES KCND3, KCNK3, KCNA3 AAK1 1159/4885LTA4H 4140/4885KMT2A 530/4885
US-10265316-B2 Hydantoin derivatives useful as Kv3 inhibitors KCNA3, KCND3, KCNN3 AAK1 1365/4885LTA4H 1620/4885KMT2A 450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.